Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 01-Oct-24 4:09 PM View:  | Xencor Inc (XNCR) | 27-Sep-24 | Sale (Planned) | 2,654 | $20.68 | $54,884.70 | (24%) 11.05K to 8.39K | |
| 17-Jun-24 4:22 PM View: | Xencor Inc (XNCR) | 13-Jun-24 | Grant | 5,986 | -- | -- | 118% 5.06K to 11.05K | |
| 14-Feb-24 5:17 PM View: | Neurocrine Biosciences Inc. (NBIX) | 13-Feb-24 | Option Exercise | 5,090 | $39.28 | $199,951.00 | 1% 506.96K to 512.05K | |
| 15-Feb-24 5:43 PM View: | Neurocrine Biosciences Inc. (NBIX) | 13-Feb-24 | Private Sale (Planned) | 2,832 | $133.02 | $376,700.00 | (< 1%) 517.43K to 514.6K | |
| 15-Feb-24 4:02 PM View: | Xencor Inc (XNCR) | 13-Feb-24 | Private Purchase | 53 | $19.12 | $1,013.36 | 1% 5.01K to 5.06K | |
| 08-Feb-24 7:21 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Feb-24 | Sale (Planned) | 2,274 | $134.15 | $305,052.00 | (< 1%) 509.24K to 506.96K | |
| 08-Feb-24 7:21 PM View: | Neurocrine Biosciences Inc. (NBIX) | 06-Feb-24 | Private Sale (Planned) | 3,040 | $142.18 | $432,218.00 | (< 1%) 507.96K to 504.92K | |
| 02-Feb-24 7:21 PM View: | Neurocrine Biosciences Inc. (NBIX) | 31-Jan-24 | Private Sale (Planned) | 2,707 | $140.69 | $380,845.00 | (< 1%) 504.89K to 502.19K | |
| 10-Jan-24 4:31 PM View: | Neurocrine Biosciences Inc. (NBIX) | 09-Jan-24 | Option Exercise | 62,023 | $19.59 | $1,215,030.00 | 12% 499.75K to 561.78K | |
| 10-Jan-24 4:31 PM View: | Neurocrine Biosciences Inc. (NBIX) | 09-Jan-24 | Planned Option Sale | 62,023 | $134.01 | $8,311,900.00 | (11%) 561.78K to 499.75K | |
| 10-Jan-24 4:31 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Jan-24 | Option Exercise | 105,835 | $19.59 | $2,073,310.00 | 21% 499.75K to 605.59K | |
| 10-Jan-24 4:31 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Jan-24 | Planned Option Sale | 105,835 | $132.44 | $14,016,500.00 | (17%) 605.59K to 499.75K | |
| 23-Aug-23 8:08 PM View: | Neurocrine Biosciences Inc. (NBIX) | 21-Aug-23 | Private Sale (Planned) | 9,328 | $107.40 | $1,001,820.00 | (2%) 509.08K to 499.75K | |
| 22-Jun-23 5:55 PM View: | Xencor Inc (XNCR) | 20-Jun-23 | Grant | 5,007 | -- | -- | 100% 0 to 5.01K | |
| 08-Feb-23 7:28 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Feb-23 | Sale (Planned) | 2,274 | $104.30 | $237,185.00 | (< 1%) 493.64K to 491.37K | |
| 08-Feb-23 7:28 PM View: | Neurocrine Biosciences Inc. (NBIX) | 07-Feb-23 | Sale (Planned) | 23,730 | $102.42 | $2,430,310.00 | (5%) 513.05K to 489.32K | |
| 08-Feb-23 7:28 PM View: | Neurocrine Biosciences Inc. (NBIX) | 06-Feb-23 | Private Sale (Planned) | 3,040 | $105.68 | $321,259.00 | (< 1%) 471.05K to 468.01K | |
| 02-Feb-23 5:19 PM View: | Neurocrine Biosciences Inc. (NBIX) | 31-Jan-23 | Private Sale (Planned) | 2,707 | $110.08 | $297,997.00 | (< 1%) 467.99K to 465.28K | |
| 09-Feb-22 7:00 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Feb-22 | Sale (Planned) | 2,274 | $79.49 | $180,768.00 | (< 1%) 465.12K to 462.84K | |
| 09-Feb-22 7:00 PM View: | Neurocrine Biosciences Inc. (NBIX) | 07-Feb-22 | Private Sale (Planned) | 8,710 | $80.82 | $703,907.00 | (2%) 469.51K to 460.8K | |
| 09-Feb-21 9:17 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Feb-21 | Market Sale (Planned) | 10,466 | $116.75 | $1,221,860.00 | (2%) 463.44K to 452.97K | < 1% |
| 09-Feb-21 9:17 PM View: | Neurocrine Biosciences Inc. (NBIX) | 05-Feb-21 | Market Sale (Planned) | 2,422 | $114.16 | $276,504.00 | (< 1%) 445.67K to 443.25K | (1%) |
| 12-Jan-21 4:16 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Jan-21 | Option Exercise | 308,250 | $8.65 | $2,667,800.00 | 70% 441.07K to 749.32K | |
| 12-Jan-21 4:16 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Jan-21 | Market Option Sale (Planned) | 308,250 | $110.21 | $33,973,900.00 | (41%) 749.32K to 441.07K | (5%) |
| 16-Nov-20 6:16 PM View: | Neurocrine Biosciences Inc. (NBIX) | 12-Nov-20 | Market Sale (Planned) | 3,390 | $90.78 | $307,748.00 | (< 1%) 444.46K to 441.07K | (27%) |
| 07-Aug-20 7:29 PM View: | Neurocrine Biosciences Inc. (NBIX) | 05-Aug-20 | Market Sale (Planned) | 3,390 | $118.91 | $403,101.00 | (< 1%) 441.41K to 438.02K | 3% |
| 28-Apr-20 8:41 PM View: | Neurocrine Biosciences Inc. (NBIX) | 24-Apr-20 | Market Sale (Planned) | 2,906 | $99.45 | $289,016.00 | (< 1%) 437.88K to 434.97K | (16%) |
| 11-Feb-20 7:14 PM View: | Neurocrine Biosciences Inc. (NBIX) | 07-Feb-20 | Market Sale (Planned) | 3,248 | $103.36 | $335,696.00 | (< 1%) 435.61K to 432.36K | (12%) |
| 07-Feb-20 6:44 PM View: | Neurocrine Biosciences Inc. (NBIX) | 06-Feb-20 | Market Sale (Planned) | 4,343 | $101.56 | $441,068.00 | (1%) 433.78K to 429.44K | (14%) |
| 07-Feb-20 6:44 PM View: | Neurocrine Biosciences Inc. (NBIX) | 05-Feb-20 | Market Sale (Planned) | 5,449 | $103.09 | $561,726.00 | (1%) 430.98K to 425.53K | (12%) |
| 13-Aug-19 4:44 PM View: | Neurocrine Biosciences Inc. (NBIX) | 09-Aug-19 | Option Exercise | 3,031 | $32.99 | $99,992.70 | < 1% 417.6K to 420.63K | |
| 08-Aug-19 7:39 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Aug-19 | Option Exercise | 26,330 | $8.66 | $228,018.00 | 6% 417.6K to 443.93K | |
| 08-Aug-19 7:39 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Aug-19 | Market Option Sale (Planned) | 26,330 | $95.64 | $2,518,150.00 | (6%) 443.93K to 417.6K | (21%) |
| 08-Aug-19 7:39 PM View: | Neurocrine Biosciences Inc. (NBIX) | 07-Aug-19 | Option Exercise | 2,759 | $8.66 | $23,892.90 | < 1% 417.6K to 420.36K | |
| 08-Aug-19 7:39 PM View: | Neurocrine Biosciences Inc. (NBIX) | 07-Aug-19 | Market Option Sale (Planned) | 2,759 | $95.12 | $262,440.00 | (< 1%) 420.36K to 417.6K | (22%) |
| 08-Aug-19 7:39 PM View: | Neurocrine Biosciences Inc. (NBIX) | 06-Aug-19 | Option Exercise | 50,911 | $8.66 | $440,889.00 | 12% 417.6K to 468.51K | |
| 08-Aug-19 7:39 PM View: | Neurocrine Biosciences Inc. (NBIX) | 06-Aug-19 | Market Option Sale (Planned) | 50,911 | $95.15 | $4,844,380.00 | (11%) 468.51K to 417.6K | (21%) |
| 08-Feb-19 5:09 PM View: | Neurocrine Biosciences Inc. (NBIX) | 06-Feb-19 | Market Sale (Planned) | 4,096 | $84.22 | $344,986.00 | (< 1%) 421.69K to 417.6K | (37%) |
| 06-Feb-19 6:03 PM View: | Neurocrine Biosciences Inc. (NBIX) | 05-Feb-19 | Market Sale (Planned) | 4,489 | $88.19 | $395,895.00 | (1%) 418.43K to 413.94K | (31%) |
| 06-Feb-19 6:03 PM View: | Neurocrine Biosciences Inc. (NBIX) | 04-Feb-19 | Market Sale (Planned) | 3,125 | $88.10 | $275,321.00 | (< 1%) 411.21K to 408.08K | (31%) |
| 29-Jun-18 7:32 PM View: | Neurocrine Biosciences Inc. (NBIX) | 28-Jun-18 | Option Exercise | 57,924 | $9.21 | $533,416.00 | 17% 347.03K to 404.96K | |
| 03-May-18 7:39 PM View: | Neurocrine Biosciences Inc. (NBIX) | 01-May-18 | Option Exercise | 126,832 | $5.76 | $730,552.00 | 37% 347.03K to 473.87K | |
| 03-May-18 7:39 PM View: | Neurocrine Biosciences Inc. (NBIX) | 01-May-18 | Market Option Sale (Planned) | 126,832 | $80.75 | $10,241,700.00 | (27%) 473.87K to 347.03K | (43%) |
| 07-Feb-18 6:06 PM View: | Neurocrine Biosciences Inc. (NBIX) | 06-Feb-18 | Payment of Exercise | 4,091 | $82.48 | $337,426.00 | (< 1%) 451.12K to 447.03K | (40%) |
| 07-Feb-18 6:06 PM View: | Neurocrine Biosciences Inc. (NBIX) | 06-Feb-18 | Option Exercise | 100,000 | $5.76 | $576,000.00 | 28% 351.12K to 451.12K | |
| 07-Feb-18 6:06 PM View: | Neurocrine Biosciences Inc. (NBIX) | 06-Feb-18 | Market Option Sale (Planned) | 94,017 | $80.07 | $7,527,580.00 | (21%) 447.03K to 353.02K | (44%) |
| 07-Feb-18 6:06 PM View: | Neurocrine Biosciences Inc. (NBIX) | 06-Feb-18 | Market Sale (Planned) | 5,983 | $80.07 | $479,036.00 | (2%) 353.02K to 347.03K | (44%) |
| 07-Feb-18 6:06 PM View: | Neurocrine Biosciences Inc. (NBIX) | 05-Feb-18 | Market Option Sale (Planned) | 5,983 | $83.26 | $498,164.00 | (2%) 348.86K to 342.87K | (39%) |
| 18-Jan-18 4:09 PM View: | Neurocrine Biosciences Inc. (NBIX) | 16-Jan-18 | Market Sale (Planned) | 3,750 | $78.89 | $295,820.00 | (1%) 340.11K to 336.36K | (47%) |
| 03-May-17 6:42 PM View: | Neurocrine Biosciences Inc. (NBIX) | 02-May-17 | Option Exercise | 21,739 | $2.59 | $56,304.00 | 7% 332.61K to 354.35K |